| Product Code: ETC7809291 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kenya Orexin Receptor Antagonists Market Overview |
3.1 Kenya Country Macro Economic Indicators |
3.2 Kenya Orexin Receptor Antagonists Market Revenues & Volume, 2021 & 2031F |
3.3 Kenya Orexin Receptor Antagonists Market - Industry Life Cycle |
3.4 Kenya Orexin Receptor Antagonists Market - Porter's Five Forces |
3.5 Kenya Orexin Receptor Antagonists Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.6 Kenya Orexin Receptor Antagonists Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Kenya Orexin Receptor Antagonists Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Kenya Orexin Receptor Antagonists Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Kenya Orexin Receptor Antagonists Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of sleep disorders in Kenya |
4.2.2 Growing awareness about the benefits of orexin receptor antagonists in treating sleep disorders |
4.2.3 Rise in healthcare expenditure and investments in the pharmaceutical sector in Kenya |
4.3 Market Restraints |
4.3.1 High cost associated with orexin receptor antagonist drugs |
4.3.2 Limited availability of advanced healthcare facilities in certain regions of Kenya |
4.3.3 Stringent regulatory processes for drug approvals in the country |
5 Kenya Orexin Receptor Antagonists Market Trends |
6 Kenya Orexin Receptor Antagonists Market, By Types |
6.1 Kenya Orexin Receptor Antagonists Market, By Dosage |
6.1.1 Overview and Analysis |
6.1.2 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Dosage, 2021- 2031F |
6.1.3 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By 5mg, 2021- 2031F |
6.1.4 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By 10mg, 2021- 2031F |
6.1.5 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By 15mg, 2021- 2031F |
6.1.6 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By 20mg, 2021- 2031F |
6.2 Kenya Orexin Receptor Antagonists Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Suvorexant, 2021- 2031F |
6.2.3 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Lemborexant, 2021- 2031F |
6.2.4 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Kenya Orexin Receptor Antagonists Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Insomnia, 2021- 2031F |
6.3.3 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Depression, 2021- 2031F |
6.3.4 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Anxiety, 2021- 2031F |
6.3.5 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Kenya Orexin Receptor Antagonists Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Kenya Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F |
7 Kenya Orexin Receptor Antagonists Market Import-Export Trade Statistics |
7.1 Kenya Orexin Receptor Antagonists Market Export to Major Countries |
7.2 Kenya Orexin Receptor Antagonists Market Imports from Major Countries |
8 Kenya Orexin Receptor Antagonists Market Key Performance Indicators |
8.1 Number of new patients prescribed with orexin receptor antagonists |
8.2 Rate of adoption of orexin receptor antagonist drugs among healthcare providers |
8.3 Patient satisfaction and improvement in quality of life after using orexin receptor antagonists |
9 Kenya Orexin Receptor Antagonists Market - Opportunity Assessment |
9.1 Kenya Orexin Receptor Antagonists Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.2 Kenya Orexin Receptor Antagonists Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Kenya Orexin Receptor Antagonists Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Kenya Orexin Receptor Antagonists Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Kenya Orexin Receptor Antagonists Market - Competitive Landscape |
10.1 Kenya Orexin Receptor Antagonists Market Revenue Share, By Companies, 2024 |
10.2 Kenya Orexin Receptor Antagonists Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |